Generics Industry News Search
 |
|
|
|
|
|
|
February 2013 News Archive |
|
|
| |
|
Perrigo Company today announced that it has launched Clobetasol emulsion propionate foam, 0.05%, the generic equivalent of Olux -E Foam, 0.05%...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Significant opportunities are expected to open up for pharmaceutical companies in the biosimilar segment, as biological drugs with a market value of over $50 billion are slated to shed their patent protection in the US alone in the next six years...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI Laboratories, Inc a New Jersey based generic topical pharmaceutical company, today announced it has entered into an agreement to purchase the topical pharmaceutical product Econazole Nitrate Cream 1% from Prasco, a privately-held pharmaceutical company located in Ohio...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Health regulators have approved a generic version of the cancer drug Doxil in a move that could ease a months-long shortage that has threatened the lives of thousands of patients...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo announced that it has received U.S. Food and Drug Administration approval for its New Drug Application (NDA) for Testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Elite Pharmaceuticals announced today that on January 31, 2013, the U.S. Food and Drug Administration approved the Company's supplemental application for the manufacturing and packaging of Naltrexone hydrochloride 50 mg tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark announces the first generic launch of Atovaquone Proguanil in the UK following the revocation of the Malarone patent in the High court in the UK...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sucampo Pharmaceuticals today announced that it, its affiliate Sucampo, Takeda Pharmaceutical Company, and certain affiliates of Takeda have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Anchen Pharmaceuticals, Par Pharmaceuticals, and Par Pharmaceutical Companies (collectively Anchen) related to an Abbreviated New Drug Application (ANDA) that Anchen filed with the U.S. Food and Drug Administration (FDA) to market a generic version of Amitiza (Lubiprostone) oral capsules, 8 mcg and 24 mcg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax today announced that it has settled all pending litigation with Shire relating to supply of its authorised generic Adderall XR under the parties' License and Distribution Agreement that was signed in January 2006...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals for approximately $283 million in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Putney Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched generic veterinary Cefpodoxime Proxetil tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Beximco Pharmaceuticals Limited has commenced export of medicines to Europe...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Last year, the US Supreme Court ruled generic drug makers are not required to strengthen labeling even when alerted to side effects...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A U.S. court has struck Baraclude from the patent list...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has entered into a definitive agreement with Biocon for an exclusive strategic collaboration on the development and commercialisation of generic versions of three insulin analog products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva may be on the hook for up to $2.1 billion in damages because it sold generic copies of Pfizer's heartburn reliever Protonix before the drug's U.S. patent exclusivity expired in 2011...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced today that the U.S. Food and Drug Administration has approved its generic version of Shire's Adderall Capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30 mg capsules for the treatment of attention deficit hyperactivity disorder...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis, Inc. today announced that it has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Actavis' generic version of the 32 mg dosage strength of Mallinckrodt's Exalgo (Hydromorphone Hydrochloride Extended-Release) tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge Pharmaceutical. announced today the immediate launch of Pioglitazone Hydrochloride Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis' s generic version of the painkiller Fentora wouldn't infringe two patents owned by Teva' s Cephalon unit, a U.S. appeals court ruled today...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Torrent gained more than one percent intraday on Friday as the company received approval from US FDA for generics of Actos and Actoplus Met...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca's new CEO Pascal Soriot had to start the year giving shareholders tough news about the U.K. company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Federal Trade Commission (FTC) recently filed a brief with the U.S. Supreme Court in a case that promises to bring some clarity to the analysis of settlements of pharmaceutical patent litigation...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for Testosterone gel 1.62% and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The FDA is considering a rule change that could pave the the way for individuals allegedly injured by generic versions of popular medications, including Fosamax, to pursue generic drugs lawsuits against their manufacturers, Bernstein Liebhard LLP reports...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sergeant's Pet Care Products, a leader in the pet supplies industry, announces the release of Sergeant's Pronyl OTC Flea and Tick Spray for Dogs and Cats, the only generic equivalent to Frontline Spray currently available...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead Sciences, today announced that Gilead and Teva have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread, a treatment for HIV infection and chronic hepatitis B...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The battle over biosimilar drugs moved ahead today in the Florida House, as the Health Quality Subcommittee approved a bill that would create standards for using a new wave of pharmaceutical products that are expected to gain in popularity in the next few years...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US launch of an authorised generic version of Eagle Pharmaceuticals ready-to-use Argatroban injection 50 mg/50mL, aqueous solution (1 mg/mL)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharmaceuticals company Bayer is suing an Australian company for selling generic versions of its patented oral contraceptive drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Indian generic drugmaker Ranbaxy said on Friday it will resume production of its version of Pfizer's cholesterol fighter Lipitor for sale in the United States after resolving the issues that led to a November recall...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Maryland among states considering restrictions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer has asked the US Supreme Court of Alabama to reconsider its decision of 4 January 2013, which would allow generics patients to sue brand-name drugmakers...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products. South Africa has the world's largest HIV/AIDS population, with approximately 5.6 million1 people living with the disease and an estimated 1.7 million2 people receiving treatment...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
U.S. regulators approved two generic versions of Reckitt Benckiser's heroin addiction drug and rejected its bid to block rival products on the grounds that stricter packaging rules were needed to protect children...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Viropro and Oncobiologics announced today the signing of a biosimilar collaboration agreement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it has received approval from the U.S. FDA on its ANDA for Buprenorphine HCl and Naloxone HCl dihydrate SL tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amneal, the 7th largest generic drug manufacturer in the U.S. market, has received U.S. FDA approval for one of the first generic versions of Suboxone sublingual tablets for maintenance treatment of opioid drug dependence...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The announcement last night that Affymax is recalling all lots of its red blood cell stimulating medicine Omontys could have broader implications for how the Food and Drug Administration (FDA) evaluates similar drugs going forward...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Claris Lifesciences announced that it has received two Abbreviated New Drug Application approvals for Ondensetron Injection in the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has signed a definitive agreement to acquire Agila Limited, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6 billion in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
